Prolidase activity is elevated in several cancers, such as breast cancer, endometrial cancer, lung cancer, melanoma, and others (Karna et al., 2000; Cechowska-Pasko et al., 2006; Mittal et al., 2007; Arioz et al., 2009). This evidence concerns the gene PEPD and lung carcinoma.